Source: Annual Congress 2008 - Defining COPD using the "fixed ratio" (FEV1/FVC <0.70) – pro and con
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. Hardie (Paradis, Norway). Implications of using the fixed ratio in diagnosing COPD in the elderly. Annual Congress 2008 - Defining COPD using the "fixed ratio" (FEV1/FVC <0.70) – pro and con

Member's Comments

No comment yet.

Related content which might interest you: AATD: Implications for our understanding of usual COPD Source: Annual Congress 2013 –Alpha-1 antitrypsin deficiency and the lung: celebrating the 50th anniversary of its first description Year: 2013 Current challenges in diagnosing and treating adults with interstitial lung disease Source: International Congress 2014 – PG01 Challenges faced when diagnosing idiopathic interstitial lung disease Year: 2014 Algorithm of differential diagnosis of COPD in the elderly and bronchial asthma developed in geriatric age Source: Eur Respir J 2006; 28: Suppl. 50, 465s Year: 2006 Fixed FEV1/FVC ratio of 0.70 and risk of under-diagnosis of airflow obstruction among young adults Source: Annual Congress 2007 - Longitudinal and cross sectional risk factors for COPD Year: 2007 Defining the role of neutrophil-to-lymphocyte ratio in COPD patients Source: Virtual Congress 2020 – Prognosis and integrated management of COPD Year: 2020 Is the GOLD guideline for diagnosing obstruction in COPD discriminatory in predicting severe future COPD-related exacerbations and death? Source: Breathe, 17 (4) 210046; 10.1183/20734735.0046-2021 Year: 2021 Failure in differentiating between asthma and COPD in elderly population Source: Eur Respir J 2005; 26: Suppl. 49, 275s Year: 2005 Measuring and quantifying acute exacerbations of COPD: pitfalls and practicalities Source: Eur Respir J 2014; 43: 662-664 Year: 2014 Cardiovascular comorbidities in hospitalised COPD patients: a determinant of future risk? Source: Eur Respir J 2015; 46: 846-849 Year: 2015 Is FEV1/FEV6 ratio a reliable  tool in COPD diagnosis ? Source: Virtual Congress 2021 – Biomarkers to phenotype COPD: prediction of exacerbations Year: 2021 Comparison of spirometric z-scores with FEV1 percent prediction in predicting exacerbations in elderly COPD patients Source: International Congress 2016 – In-patient and out-patient COPD management Year: 2016 Laboratory and clinical parameters in predicting risk of future exacerbations in both non-smoking and smoking COPD patients Source: International Congress 2014 – Systemic biomarkers for airway diseases Year: 2014 Detecting undiagnosed COPD: Using routine primary care data to select and validate candidate variables for COPD risk prediction Source: Annual Congress 2013 –Early diagnosis and effectiveness of disease management in primary care Year: 2013 Is spirometry screening useful for detecting undiagnosed COPD? Source: Annual Congress 2011 - Respiratory epidemiology: methods, definitions and phenotypes Year: 2011 Pulmonary rehabilitation for patients with COPD during and after an exacerbation-related hospitalisation: back to the future? Source: Eur Respir J, 51 (1) 1701312; 10.1183/13993003.01312-2017 Year: 2018 Pulmonary rehabilitation for patients with COPD during and after an exacerbation-related hospitalisation: back to the future? Source: Eur Respir J, 51 (1) 1702577; 10.1183/13993003.02577-2017 Year: 2018 Clinical clustering of COPD patients is useful to predict future COPD exacerbations Source: International Congress 2018 – New predictors of morbidity and mortality in COPD Year: 2018 Implications of DLCO corrected by hemoglobin concentration for lung function preoperator risk evaluation in obese and non obese stable COPD patients Source: Annual Congress 2007 - Quality, sleep and exercise - the ingredients for a perfect life! Year: 2007 Predictors of COPD in high risk individuals seen in primary care Source: International Congress 2016 – Comorbidities and exacerbations in COPD Year: 2016 Value of reversibility in evaluating obstructive lung disease in primary care Source: Eur Respir J 2004; 24: Suppl. 48, 474s Year: 2004